Apollo Hospitals Enterprise Ltd

Apollo Hospitals Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Apollo Hospitals Enterprise Ltd

₹ 6,707 -1.94%
14 Jan - close price
apollohospitals.com BSE: 508869 NSE: APOLLOHOSP
About

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.

Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies,
Primary Care & Diagnostic Clinics and several Retail Health models. [1]

Key Points

Business Segments
1) Healthcare Services (52% in H1 FY25 vs 55% in FY22): [1] [2] The company has a capacity of 10,134 beds in 73 hospitals located in India and overseas, out of which 8,709 beds are located in 45 owned hospitals, 639 beds in Day Surgery & Cradles and 790 beds are in 6 hospitals under management through operations and management contracts. [3]

Website BSE NSE
  • Market Cap ₹ 96,434 Cr.
  • Current Price ₹ 6,707
  • High / Low ₹ 7,545 / 5,691
  • Stock P/E 81.5
  • Book Value ₹ 522
  • Dividend Yield 0.24 %
  • ROCE 15.1 %
  • ROE 13.3 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has delivered good profit growth of 34.3% CAGR over last 5 years
  • Company has been maintaining a healthy dividend payout of 22.6%

Cons

  • Stock is trading at 12.9 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of Nifty 50 BSE 500 BSE Healthcare BSE 100 BSE 200

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
3,717 3,639 3,546 3,796 4,251 4,264 4,302 4,418 4,847 4,851 4,944 5,086 5,589
3,102 3,052 3,083 3,317 3,699 3,780 3,814 3,909 4,219 4,237 4,303 4,410 4,774
Operating Profit 615 587 463 479 552 484 488 509 628 614 640 675 816
OPM % 17% 16% 13% 13% 13% 11% 11% 12% 13% 13% 13% 13% 15%
8 23 34 16 23 35 20 34 26 29 37 49 44
Interest 95 94 95 93 93 100 95 106 111 113 119 116 118
Depreciation 145 149 166 148 155 153 159 167 163 167 190 177 184
Profit before tax 383 367 236 254 327 266 254 270 379 363 368 430 557
Tax % 30% 34% 59% -27% 35% 39% 43% 36% 34% 30% 30% 27% 29%
267 243 97 324 213 162 146 173 249 254 258 316 396
EPS in Rs 17.24 15.88 6.27 22.06 14.19 10.68 10.05 11.59 16.20 17.06 17.65 21.23 26.34
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
3,769 4,357 5,129 6,150 7,256 8,243 9,617 11,247 10,560 14,663 16,612 19,059 20,469
3,157 3,681 4,392 5,465 6,522 7,442 8,548 9,656 9,420 12,474 14,548 16,665 17,725
Operating Profit 612 676 737 684 734 801 1,070 1,591 1,140 2,189 2,065 2,394 2,745
OPM % 16% 16% 14% 11% 10% 10% 11% 14% 11% 15% 12% 13% 13%
33 18 47 92 60 24 26 222 103 368 75 105 158
Interest 103 119 118 180 257 295 327 533 449 379 381 449 466
Depreciation 142 168 212 264 314 359 396 620 573 601 615 687 719
Profit before tax 399 407 455 332 222 171 373 660 221 1,578 1,144 1,362 1,719
Tax % 26% 25% 29% 29% 41% 65% 47% 34% 38% 30% 22% 33%
303 315 335 235 131 60 200 432 137 1,108 844 935 1,224
EPS in Rs 21.88 22.77 24.43 16.99 15.88 8.44 16.96 32.70 10.46 73.42 56.97 62.50 82.28
Dividend Payout % 25% 25% 24% 35% 38% 59% 35% 18% 29% 16% 26% 26%
Compounded Sales Growth
10 Years: 16%
5 Years: 15%
3 Years: 22%
TTM: 15%
Compounded Profit Growth
10 Years: 11%
5 Years: 34%
3 Years: 109%
TTM: 70%
Stock Price CAGR
10 Years: 19%
5 Years: 33%
3 Years: 10%
1 Year: 14%
Return on Equity
10 Years: 9%
5 Years: 12%
3 Years: 14%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 70 70 70 70 70 70 70 70 72 72 72 72 72
Reserves 2,677 2,907 3,102 3,262 3,244 3,182 3,264 3,270 4,531 5,551 6,126 6,864 7,429
1,213 1,344 1,992 2,834 3,125 3,427 3,673 3,596 4,160 4,068 4,332 5,333 7,371
854 1,029 1,296 1,195 1,665 1,917 2,159 4,354 2,629 3,570 3,886 4,474 4,676
Total Liabilities 4,814 5,350 6,459 7,360 8,103 8,596 9,166 11,289 11,392 13,261 14,416 16,742 19,548
2,341 2,681 3,244 3,997 4,591 4,773 4,982 7,432 6,778 8,296 8,520 9,664 10,201
CWIP 403 491 533 562 347 712 822 236 234 46 610 873 1,042
Investments 527 322 311 352 406 352 462 434 1,343 816 574 986 1,012
1,543 1,855 2,372 2,448 2,759 2,759 2,901 3,187 3,037 4,104 4,712 5,219 7,293
Total Assets 4,814 5,350 6,459 7,360 8,103 8,596 9,166 11,289 11,392 13,261 14,416 16,742 19,548

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
443 373 470 597 623 537 905 1,293 1,265 1,696 1,377 1,920
-733 -356 -759 -888 -1,152 -405 -711 -289 -880 -747 -857 -1,537
373 -63 392 330 477 -108 -215 -910 -340 -792 -633 -311
Net Cash Flow 83 -46 103 39 -52 24 -20 94 44 158 -113 72

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 46 44 43 36 38 37 39 33 46 44 49 48
Inventory Days 43 47 50 49 47 51 46 49 16 21 17 17
Days Payable 53 55 59 66 51 55 56 60 74 79 82 88
Cash Conversion Cycle 36 36 34 19 34 33 29 22 -12 -14 -16 -23
Working Capital Days 17 28 30 27 30 25 16 9 12 13 18 2
ROCE % 13% 12% 12% 9% 8% 7% 10% 14% 8% 17% 14% 15%

Shareholding Pattern

Numbers in percentages

1 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.33%
52.41% 50.81% 48.48% 49.09% 47.94% 46.96% 47.93% 46.15% 46.25% 45.63% 43.92% 45.37%
12.17% 12.93% 15.64% 15.28% 16.56% 17.76% 17.02% 18.59% 18.87% 19.55% 21.13% 19.94%
0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23%
5.86% 6.70% 6.32% 6.07% 5.94% 5.72% 5.49% 5.68% 5.32% 5.26% 5.38% 5.12%
No. of Shareholders 99,1351,26,2261,46,3201,35,9231,31,6361,31,9371,20,0301,31,5651,19,5781,30,6641,27,7541,19,245

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls